Understanding how clinical trials are delivered starts with clarity on the roles that shape them. Our latest blog explains how sponsors set the research agenda and retain oversight, how CROs manage operational delivery...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Collaborative R&D: Partnerships shaping the future of biopharma
Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.
-
US Pharma and Biotech Summit 2024: Evolving clinical research
In this news article, Applied Clinical Trials reports on ICON CEO Steve Cutler’s discussion at the FT US Pharma and Biotech Summit. Topics addressed included the evolution of the CRO and sponsor relationship, the potential of AI in the clinical development space, and how ICON is helping customers build strong portfolios.
-
Toward more intelligent collaboration: implementing data in partnerships
In this article from Pharmaceutical Outsourcing, Debbie Gilmore, Vice President, Strategic Alliance Management, Ruth Lalor, Vice President, Business Operations and Robert Ellison, Vice President, Data & Applied Analytics, outline how data can play a key role in supporting collaboration and achieving objectives, as strategic partnerships become more important in clinical research outsourcing models.
-
Continued investment key to our success as a life sciences hotspot
In this Irish Times article, Brendan Brennan, CFO, outlines how Ireland’s strong culture of partnership and collaboration, in addition to scientific and technical expertise, has played an important part in the success of the life sciences industry in Ireland.
-
Shaking it up: The partnership paradigm in clinical research
Jeff James, Executive Vice President, Alliance Management, explores how outsourcing methodologies between large pharmaceutical companies and CROs have rapidly evolved across the healthcare and clinical research landscape.
Read the article on page 13 of the December issue of PharmaTimes.
-
Evolution in the outsourcing of clinical research
Partnership is an increasingly important criterium for bio/pharmaceutical sponsors as they seek more bespoke solutions and the flexibility of tailored, blended outsourcing models.
DiPietro, M. Elaboration, Expansion, and Evolution in Outsourcing of Clinical Research. Pharmaceutical Technology 2023 47 (12) 31–33
-
Harmonising outsourcing to keep clinical trials on track
In this article in Applied Clinical Trials, Debbie Gilmore, Vice President, Strategic Alliance Management outlines how strategic partnerships and partnership-driven approaches to outsourcing can be used to navigate an increasingly complex clinical research landscape.
-
The Pharma Letter Podcast: CRO sector surges in bio revolution
This episode of The Pharma Letter Podcast features an interview with ICON’s Chief Commercial Officer, George McMillan, who outlines how ICON is growing in size to take advantage of increasing demand for its services.
-
Modern partnerships with CROs
In this article in Contract Pharma, ICON SMEs share insight on strategic and blended outsourcing models and trends in today’s market.
-
ICON partners with US Government for clinical trials of Covid-19 vaccines
The article on Clinical Trials Arena reports that ICON will conduct a phase 2b clinical trial for the US BARDA-selected Covid-19 vaccine candidate as part of Project NextGen.
